130 related articles for article (PubMed ID: 28131194)
1. Plasticity of static graviceptive function in patients with cervical dystonia.
Platho-Elwischger K; Kranz G; Sycha T; Dunkler D; Rommer P; Mueller C; Auff E; Wiest G
J Neurol Sci; 2017 Feb; 373():230-235. PubMed ID: 28131194
[No Abstract] [Full Text] [Related]
2. The effect of a single botulinum toxin treatment on somatosensory processing in idiopathic isolated cervical dystonia: an observational study.
De Pauw J; Cras P; Truijen S; Mercelis R; Michiels S; Saeys W; Vereeck L; Hallemans A; De Hertogh W
J Neurol; 2018 Nov; 265(11):2672-2683. PubMed ID: 30196326
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
4. Duration of effectiveness of botulinum toxin type B in the treatment of cervical dystonia.
Lew MF
Adv Neurol; 2004; 94():211-5. PubMed ID: 14509675
[No Abstract] [Full Text] [Related]
5. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
[No Abstract] [Full Text] [Related]
6. Perception of spatial orientation in spasmodic torticollis. Part 2: The visual vertical.
Anastasopoulos D; Bhatia K; Bronstein AM; Marsden CD; Gresty MA
Mov Disord; 1997 Sep; 12(5):709-14. PubMed ID: 9380053
[TBL] [Abstract][Full Text] [Related]
7. The position of the head in space: a kinematic analysis in patients with cervical dystonia treated with botulinum toxin.
Albani G; Bulgheroni MV; Mancini F; Mauro A; Fundarò C; Pacchetti C; Sandrini G; Nappi G
Funct Neurol; 2001; 16(2):135-41. PubMed ID: 11495419
[TBL] [Abstract][Full Text] [Related]
8. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
[TBL] [Abstract][Full Text] [Related]
9. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
Mueller J
Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
[No Abstract] [Full Text] [Related]
10. Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure.
Dressler D; Bigalke H
J Neurol; 2005 Aug; 252(8):904-7. PubMed ID: 15761672
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin therapy for cervical dystonia.
Jankovic J
Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
[TBL] [Abstract][Full Text] [Related]
12. Perception of spatial orientation in spasmodic torticollis. Part I: The postural vertical.
Anastasopoulos D; Bhatia K; Bisdorff A; Bronstein AM; Gresty MA; Marsden CD
Mov Disord; 1997 Jul; 12(4):561-9. PubMed ID: 9251075
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in individuals with cervical dystonia before botulinum toxin injection in a Brazilian tertiary care hospital.
Queiroz MR; Chien HF; Barbosa ER
Arq Neuropsiquiatr; 2011 Dec; 69(6):900-4. PubMed ID: 22297876
[TBL] [Abstract][Full Text] [Related]
14. Natural history of posttraumatic cervical dystonia.
Frei KP; Pathak M; Jenkins S; Truong DD
Mov Disord; 2004 Dec; 19(12):1492-8. PubMed ID: 15390063
[TBL] [Abstract][Full Text] [Related]
15. Autonomic side effects of botulinum toxin type B therapy.
Dressler D; Benecke R
Adv Neurol; 2004; 94():315-20. PubMed ID: 14509689
[No Abstract] [Full Text] [Related]
16. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
17. Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.
Jankovic J; Hunter C; Dolimbek BZ; Dolimbek GS; Adler CH; Brashear A; Comella CL; Gordon M; Riley DE; Sethi K; Singer C; Stacy M; Tarsy D; Atassi MZ
Neurology; 2006 Dec; 67(12):2233-5. PubMed ID: 17190952
[TBL] [Abstract][Full Text] [Related]
18. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment].
Domzał TM
Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
20. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
Dressler D; Kupsch A; Seitzinger A; Paus S
Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
